期刊文献+

晚期氧化蛋白产物诱导血管平滑肌细胞表达MCP-1及其信号转导通路的研究 被引量:5

Signal transduction of advanced oxidation protein products induced MCP-1 expressions in vascular smooth muscle cells
下载PDF
导出
摘要 目的研究p38有丝分裂素激活蛋白激酶(p38 mitogen-activated protein kinase,MAPK)在晚期氧化蛋白产物(advanced oxidation protein products,AOPP)诱导的鼠血管平滑肌细胞单核细胞趋化蛋白-1表达中的作用。方法使用200和400μmol/LAOPP分别以不同时间刺激培养的鼠血管平滑肌细胞,在阻断实验中加入特异性p38MAPK阻断剂SB203580阻断p38MAPK信号转导通路。采用免疫印迹法(Western blot)检测细胞中MCP-1和磷酸化p38MAPK的表达情况。结果用特异性p38MAPK阻断剂SB203580预处理后,400μmol/LAOPP刺激4h的鼠血管平滑肌细胞MCP-1表达(平均灰度值)从42.00±0.95降至9.35±1.35受到显著抑制(P<0.01)。结论①p38MAPK信号转导途径参与了AOPP诱导的鼠血管平滑肌细胞MCP-1的表达。②晚期氧化蛋白产物促进平滑肌细胞MCP-1 mRNA和蛋白表达可能是其致动脉粥样硬化机制之一。 Objective To investigate the role of p38MAPK signaling pathway in advanced oxidation protein products (AOPP) induced expressions of monocyte chemotactic protein-1 ( MCP-1 ) in vascular smooth muscle cells (VSMCs). Methods Vascular smooth muscle cells (VSMCs) were cultured and then co-incubated with AOPP (200,400 μmoL/L) for different time with or without the pretreatment of specific p38MAPK inhibitor SB203580. Western blot was used to detect the expression of phosphorylated p38MAPK. Results The expression of phosphorylated p38MAPK was increased after AO after stimulation, then decreased. The expression of MCP-1 SB203580 as compared pression in VSMCs and with that in the AOPP group ( P 〈 0.0 contributes to the formation of atheroscl mediated at least in part through the activation of p38MAPK PP treatment and reached the highest level 4 h was down-regulated with the pretreatment of 1 ). Conclusion AOPP stimulates MCP-1 exerosis through this proinflammatory effect that is signaling pathway.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第2期101-103,共3页 Journal of Third Military Medical University
基金 国家自然科学基金(30470807)~~
关键词 晚期氧化蛋白产物 单核细胞趋化蛋白-1 有丝分裂素激活蛋白激酶类 鼠血管平滑肌细胞 动脉粥样硬化 advanced oxidation protein products p38 mitogen-activated protein kinase monocyte chemotactic protein-1 vascular smooth muscle cells atherosclerosis
  • 相关文献

参考文献12

  • 1Witko-Sarsat V,Friedlander M,Capeillere-Blandin C,et al.Advanced oxidation protein products as a novel marker of oxidative stress in uremia[J].Kidney Int,1996,49(5):1304-1313.
  • 2袁方,刘尚喜,侯凡凡,陈瑗,田建伟,刘志强.晚期氧化蛋白产物导致血管内皮细胞氧化应激损伤[J].解放军医学杂志,2004,29(11):951-954. 被引量:20
  • 3Witko-Sarsat V,Friedlander M,Nguyen-Khoa T,et al.Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure[J].J Immunol,1998,161(5):2524 -2532.
  • 4彭侃夫,吴雄飞,赵洪雯,孙岩,吴亿,王军霞.晚期氧化蛋白产物对血管平滑肌细胞单核细胞趋化蛋白-1表达的影响[J].中国血液净化,2006,5(5):252-255. 被引量:4
  • 5Stambe C,Atkins R C,Tesch G H,et al.The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis[J].J Am Soc Nephrol,2004,15(2):370 -379.
  • 6Wilmer W A,Dixon C L,Hebert C.Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway[J].Kidney Int,2001,60(3):858 -871.
  • 7Chang P C,Chen T H,Chang C J,et al.Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway[J].Kidney Int,2004,65 (5):1664-1675.
  • 8Sakai N,Wada T,Furuichi K,et al.Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy[J].Am J Kidney Dis,2005,45 (1):54-65.
  • 9Fujita H,Omori S,Ishikura K,et al.ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells[J].Am J Physiol Renal Physiol,2004,286(1):F120-F126.
  • 10Dhanasekaran N,Premkumar-Reddy E.Signaling by dual specificity kinases[J].Oncogene,1998,17 (11 Reviews):1447-1455.

二级参考文献29

  • 1袁方,刘尚喜,侯凡凡,陈瑗,田建伟,刘志强.晚期氧化蛋白产物导致血管内皮细胞氧化应激损伤[J].解放军医学杂志,2004,29(11):951-954. 被引量:20
  • 2[1]Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 1996, 49(5):1304
  • 3[2]Witko-Sarsat V, Friedlander M, Nguyen AT et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol,1998, 161(5):2524
  • 4[3]Witko-Sarsat V, Gausson V, Nguyen AT et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int, 2003, 64(1):82
  • 5[4]Kaneda H, Taguchi J, Ogasawara K et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis, 2002, 162(1):221
  • 6[5]Drueke T, Witko-Sarsat V, Massy Z et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation, 2002, 106(17):2212
  • 7[7]Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods, 1989, 119(2):203
  • 8[8]Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol, 1994, 55(2):253
  • 9[9]SX, Chen Y, Zhou M et al. Inhibitory effect of ebselen on the oxidation of low density lipoprotein. Redox Report, 1995,1:357
  • 10[10]Jungers P, Massy ZA, Khoa TN et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant, 1997,12(12):2597

共引文献22

同被引文献46

  • 1Claire B. POLLOCK,Kathleen KELLY.Mechanisms of cancer metastasis to the bone[J].Cell Research,2005,15(1):57-62. 被引量:51
  • 2Neff R L, Farrar W B, Kloos R T, et al. Anaplastic thyroid cancer [J]. Endocrinol Metab Clin North Am, 2008, 37(2) : 525 -538, ix.
  • 3Fruehauf J P, Meyskens F L Jr. Reactive oxygen species : a breath of life or death? [J]. Clin Cancer Res, 2007, 13(3) : 789 -794.
  • 4Lau A T, Wang Y, Chiu J F. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic [ J ]. J cell Biochem, 2008, 104(2): 657-667.
  • 5Raman M, Chen W, Cobb M H. Differential regulation and properties of MAPKs[J]. Oncogene, 2007, 26(22): 3100-3112.
  • 6Tsuchiya T, Tsuno N H, Asakage M, et al. Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells[J]. Hepatogastroenterology, 2008, 55 (84) : 930 - 935.
  • 7Fei H, Zhao B, Zhao S, et al. Requirements of calcium fluxes and ERK kinase activation for glucose- and interleukin-lbeta-induced beta-cell apoptosis [J]. Mol Cell Biochem, 2008, 315(1 -2) : 75 -84.
  • 8李桂源主编.病理生理学[M].2版.北京:人民卫生出版社,2010:34-38.
  • 9Urbansky ET, Schock MR. Issues in managing the risks associated with perchloratein drinking water [J]. J Environ Manag, 1999, 56: 79-95.
  • 10Mendiratta SK, Dotson RL, Brooker RT. Perchloric acid and perchlorates//Kirk-Othmer Encyclopedia of Chemical Technology [M].New York: John Wiley Sons, Inc, 1996: 157-170.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部